Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methodological advances in the discovery of novel neuroblastoma therapeutics.
Segura MF, Soriano A, Roma J, Piskareva O, Jiménez C, Boloix A, Fletcher JI, Haber M, Gray JC, Cerdá-Alberich L, Martínez de Las Heras B, Cañete A, Gallego S, Moreno L. Segura MF, et al. Among authors: piskareva o. Expert Opin Drug Discov. 2022 Feb;17(2):167-179. doi: 10.1080/17460441.2022.2002297. Epub 2021 Nov 22. Expert Opin Drug Discov. 2022. PMID: 34807782 Review.
MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.
Soriano A, París-Coderch L, Jubierre L, Martínez A, Zhou X, Piskareva O, Bray I, Vidal I, Almazán-Moga A, Molist C, Roma J, Bayascas JR, Casanovas O, Stallings RL, Sánchez de Toledo J, Gallego S, Segura MF. Soriano A, et al. Among authors: piskareva o. Oncotarget. 2016 Feb 23;7(8):9271-87. doi: 10.18632/oncotarget.7005. Oncotarget. 2016. PMID: 26824183 Free PMC article.
Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.
Soriano A, Masanas M, Boloix A, Masiá N, París-Coderch L, Piskareva O, Jiménez C, Henrich KO, Roma J, Westermann F, Stallings RL, Sábado C, de Toledo JS, Santamaria A, Gallego S, Segura MF. Soriano A, et al. Among authors: piskareva o. Cell Mol Life Sci. 2019 Jun;76(11):2231-2243. doi: 10.1007/s00018-019-03041-4. Epub 2019 Feb 15. Cell Mol Life Sci. 2019. PMID: 30770954 Free PMC article.
Preclinical models for neuroblastoma: Advances and challenges.
Nolan JC, Frawley T, Tighe J, Soh H, Curtin C, Piskareva O. Nolan JC, et al. Among authors: piskareva o. Cancer Lett. 2020 Apr 1;474:53-62. doi: 10.1016/j.canlet.2020.01.015. Epub 2020 Jan 18. Cancer Lett. 2020. PMID: 31962141 Free article. Review.
A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models.
Curtin C, Nolan JC, Conlon R, Deneweth L, Gallagher C, Tan YJ, Cavanagh BL, Asraf AZ, Harvey H, Miller-Delaney S, Shohet J, Bray I, O'Brien FJ, Stallings RL, Piskareva O. Curtin C, et al. Among authors: piskareva o, o brien fj. Acta Biomater. 2018 Apr 1;70:84-97. doi: 10.1016/j.actbio.2018.02.004. Epub 2018 Feb 12. Acta Biomater. 2018. PMID: 29447961 Free article.
30 results